1. Vogel, V. G. (2018). Epidemiology of breast cancer. In K. I. Bland, E. M. Copeland 3rd, V. S. Klimberg, & W. J. Gradishar (Eds.), The breast (5th ed., pp. 207–218. e204). Amsterdam: Elsevier. ISBN:978-0-323-35955-9.
2. Nafissi, N., Khayamzadeh, M., Zeinali, Z., Pazooki, D., Hosseini, M., & Akbari, M. E. (2018). Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern Countries. Middle East Journal of Cancer, 9(3), 243–251.
3. National Comprehensive Cancer Network. (2003). Breast cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 1(2), 148–188.
4. Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., et al. (2011). Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. The Journal of Clinical Investigation, 121(7), 2750–2767.
5. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). (1992). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet, 339(8784), 1–15.